[{"NetIncomeLoss_1_Q1_USD":-13445000.0,"PreferredStockSharesOutstanding_0_Q1_shares":488000.0,"MarketableSecuritiesCurrent_0_Q1_USD":145803000.0,"DepreciationAndAmortization_1_Q1_USD":218000.0,"GuaranteeObligationsCurrentCarryingValue_0_Q1_USD":1255000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q1_USD":3143000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":4297000.0,"ValueAddedTaxReceivableCurrent_0_Q1_USD":258000.0,"InterestPaidNet_1_Q1_USD":3234000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-22306000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":11191000.0,"ProceedsFromDivestitureOfBusinesses_1_Q1_USD":8250000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-718000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":353000.0,"AssetsCurrent_0_Q1_USD":242314000.0,"LongTermDebtCurrent_0_Q1_USD":0.0,"DepositsAssetsCurrent_0_Q1_USD":1477000.0,"RestructuringCharges_1_Q1_USD":-53000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":11012000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":15275.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":106000.0,"IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_1_Q1_USD":618000.0,"IncomeTaxesPaidNet_1_Q1_USD":0.0,"CommonStockSharesIssued_0_Q1_shares":58488000.0,"GuarantyLiabilities_0_Q1_USD":983000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-537000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":145803000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":149000.0,"DebtSecuritiesAvailableForSaleRealizedLoss_1_Q1_USD":68000.0,"OtherLongTermDebt_0_Q1_USD":13000.0,"EarningsPerShareBasic_1_Q1_USD":-0.23,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":58443000.0,"PrepaidExpenseCurrent_0_Q1_USD":4990000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-2112000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":0.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-2607000.0,"CommonStockValue_0_Q1_USD":584000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_1_Q1_USD":-477000.0,"InvestmentIncomeNet_1_Q1_USD":610000.0,"CapitalizedContractCostNet_0_Q1_USD":0.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.162,"ProceedsFromIssuanceOfPrivatePlacement_1_Q1_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":149000.0,"StockIssuedDuringPeriodValueOther_1_Q1_USD":0.0,"CostsAndExpenses_1_Q1_USD":14811000.0,"OtherAssetsCurrent_0_Q1_USD":149000.0,"IncreaseDecreaseInInventories_1_Q1_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-14700000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-3789000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":0.0,"OtherAssetsNoncurrent_0_Q1_USD":27717000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":59172000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":1717000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":542093000.0,"Liabilities_0_Q1_USD":156437000.0,"Assets_0_Q1_USD":292941000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-1255000.0,"ShareBasedCompensation_1_Q1_USD":1728000.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":561000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":1448000.0,"Goodwill_0_Q1_USD":16836000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1728000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-23413000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1_Q1_USD":40736000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":58443000.0,"WorkersCompensationLiabilityCurrent_0_Q1_USD":738000.0,"LiabilitiesCurrent_0_Q1_USD":9120000.0,"AccountsPayableCurrent_0_Q1_USD":2824000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":59172000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":34231000.0,"LongTermDebtNoncurrent_0_Q1_USD":141461000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":1670000.0,"InterestExpenseDebt_1_Q1_USD":1929000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":0.0,"PaymentsForRoyalties_1_Q1_USD":0.0,"RestructuringReserveCurrent_0_Q1_USD":287000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":43000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"PreferredStockSharesIssued_0_Q1_shares":488000.0,"BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_0_Q1_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q1_USD":-55000.0,"DebtSecuritiesAvailableForSaleRealizedGain_1_Q1_USD":11000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":344000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-1255000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":37769000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.23,"CommonStockSharesOutstanding_0_Q1_shares":58488000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":2427000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"DeferredTaxAssetsNet_0_Q1_USD":20790000.0,"IncreaseDecreaseInAccruedTaxesPayable_1_Q1_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":3736000.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":0.0,"OperatingIncomeLoss_1_Q1_USD":-14811000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-16052000.0,"IncomeTaxesReceivable_0_Q1_USD":18835000.0,"PreferredStockValue_0_Q1_USD":5000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":3852000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-2534000.0,"PreferredStockSharesAuthorized_0_Q1_shares":50000000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":484000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":4139000.0,"DueToAffiliateCurrent_0_Q1_USD":0.0,"OtherLiabilitiesCurrent_0_Q1_USD":1515000.0,"StockholdersEquity_0_Q1_USD":136504000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":26000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":144708000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":312000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-383872000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-12550000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":292941000.0,"BusinessCombinationAcquisitionRelatedCosts_1_Q1_USD":0.0,"Ticker":"AVDL","CIK":"1012477","name":"AVADEL PHARMACEUTICALS PLC","OfficialName":"Avadel Pharmaceuticals plc American Depositary Shares","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"391383731.0","Country":"France","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]